TABLE 1

Characteristics of EV populations and subpopulations

PopulationSubpopulationSizeSuggested Marker or CargoReference
Exosomes30–150 nmSyntenin, LAMP1/2, ALIX, TSG101, CD63(Andreu and Yáñez-Mó, 2014; Greening et al., 2017; Mathieu et al., 2021)
Ectosomes50–10,000 nmAnnexin A1/2, basigin, SLC3A2(Jeppesen et al., 2019; Mathieu et al., 2021)
Apoptotic bodies50–2000 nmICAM-3, phosphatidylserine, histones, mitochondrial content(Fadok et al., 1992; Martínez and Freyssinet, 2001; Taylor et al., 2008; Torr et al., 2012; Atkin-Smith et al., 2015)
Exopheres∼3.5 μmPhosphatidylserine, LC3, mitochondrial content(Melentijevic et al., 2017; Nicolás-Ávila et al., 2020)
Large oncosomes1–10 μmCytokeratin 18, caveolin-1, ARF6, GAPDH, HSPA5(Di Vizio et al., 2012; Minciacchi et al., 2015)
Intracellular membrane-derived ectosomes50–120 nmPhosphatidylserine, cytokines(Sun et al., 2021)
ARMMs∼50 nmTSG101, VSP4(Nabhan et al., 2012)
Midbody remnants200–600 nmMicrotubules(Rai et al., 2021)
Migrasomes50–100 nmTSPAN4, TSPAN7, cholesterol, integrins(Huang et al., 2019; Jiang et al., 2019)
Protrusion-derived ectosomes∼30 nmCholesterol, HSP90, cytoskeletal proteins, prominin-1(Hu et al., 2019; Nishimura et al., 2021; Hurbain et al., 2022; D’Angelo et al., 2023)
Extracellular particles (biogenesis unknown)ExomeresHSP90, argonaute, amyloid precursor proteins(Zhang et al., 2018; Zhang et al., 2019)
SupermeresTGF-βI, HSPA13, enolase 2(Zhang et al., 2021)